SCHEMBL1039989

SCHEMBL1039989

C1=CSSSC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479381 0.90
SCHEMBL22568 0.79
SCHEMBL17240310 0.79
SCHEMBL5670370 0.79
SCHEMBL1354746 0.76
SCHEMBL3682955 0.76
Ammonia Solution, Strong SCHEMBL15167335 0.76
Methane SCHEMBL6833942 0.76
Methane SCHEMBL2058152 0.76
Hydrochloric Acid SCHEMBL8961347 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090069407-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR REPELLING BLOOD-FEEDING ARTHROPODS AND DETERRING THEIR LANDING AND FEEDING PHERO TECH INTERNATIONAL INC. (CA) 2009-03-12 US claimed
CN-120076831-A Anti-ROR 1 antibodies and antibody conjugates, compositions comprising anti-ROR 1 antibodies or antibody conjugates, and methods of making and using anti-ROR 1 antibodies and antibody conjugates 苏特罗生物制药公司 2025-05-30 CN disclosed
CN-119823124-A Compounds for targeted degradation of BRD9 C4医药公司 2025-04-15 CN disclosed
CN-115279370-B Compounds for targeted degradation of BRD9 C4医药公司 2025-01-10 CN disclosed
CN-109476629-B Urea and thiourea substituted bicyclic derivatives as pesticides 先正达参股股份有限公司 2022-04-15 CN disclosed
EP-2272866-B1 THERAPEUTICALLY ACTIVE ALPHA-MSH ANALOGUES ABBVIE INC (US) 2018-09-19 EP disclosed
US-9951116-B2 Alpha- and gamma-MSH analogues TXP PHARMA GMBH (CH) 2018-04-24 US disclosed
US-20170174738-A1 ALPHA- AND GAMMA-MSH ANALOGUES TXP PHARMA GMBH (CH) 2017-06-22 US disclosed
US-9486495-B2 Alpha-and gamma-MSH analogues TXP PHARMA GMBH (CH) 2016-11-08 US disclosed
US-20160074469-A1 ALPHA-AND GAMMA-MSH ANALOGUES TXP PHARMA GMBH (CH) 2016-03-17 US disclosed
US-20030230363-A1 Non-toxic corrosion-protection rinses and seals based on cobalt UNIVERSITY OF DAYTON 2003-12-18 US disclosed
WO-2003060192-A1 NON-TOXIC CORROSION-PROTECTION RINSES AND SEALS BASED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed
WO-2003060191-A2 NON-TOXIC CORROSION-PROTECTION CONVERSION COATINGES ABSED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed
WO-2003060019-A1 NON-TOXIC CORROSION PROTECTION PIGMENTS BASED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed
US-20030100545-A1 Benzimidazolidinone derivatives as muscarinic agents ACADIA PHARMACEUTICALS, INC. 2003-05-29 US disclosed
WO-2003028650-A2 BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS ACADIA PHARMACEUTICALS, INC. (US) 2003-04-10 WO disclosed
US-20030032625-A1 Succinimide and maleimide derivatives and their use as topoisomerase II catalytic inhibitors TOPO TARGET APS (DK) 2003-02-13 US disclosed
US-20020161266-A1 Performing a one-pot organic reaction, which includes carbon monoxide (CO) as reactant and does not use of an external gas source, by contacting a non-catalyzing CO releasing compound such as a metal carbonyl with an energy source BIOTAGE AB (SE) 2002-10-31 US disclosed
WO-2002078679-A2 SUCCINIMIDE AND MALEIMIDE DERIVATIVES AND THEIR USE AS TOPOISOMERASE II CATALYTIC INHIBITORS TOPO TARGET APS (DK) 2002-10-10 WO disclosed
US-20020103176-A1 Male contraceptive formulation comprising norethisterone SCHERING AKTIENGESELLSCHAFT 2002-08-01 US disclosed